Avanos Medical AVNS Total Specialty Nutrition Systems — Depreciation and amortization expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept avns:DepreciationAndAmortizationExpense.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's total specialty nutrition systems — depreciation and amortization expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Avanos Medical's total specialty nutrition systems — depreciation and amortization expense?
- Avanos Medical (AVNS) reported total specialty nutrition systems — depreciation and amortization expense of -$6.1M in Q1 2026.
- How has Avanos Medical's total specialty nutrition systems — depreciation and amortization expense changed year-over-year?
- Avanos Medical's total specialty nutrition systems — depreciation and amortization expense decreased by 22.0% year-over-year, from -$5M to -$6.1M.
- What is the long-term trend for Avanos Medical's total specialty nutrition systems — depreciation and amortization expense?
- Over 2 years (2023 to 2025), Avanos Medical's total specialty nutrition systems — depreciation and amortization expense has grown at a 7.1% compound annual growth rate (CAGR), from -$17.8M to -$20.4M.
- What does total specialty nutrition systems — depreciation and amortization expense mean?
- This non-cash charge reflects the systematic allocation of the cost of tangible and intangible assets used within the specialty nutrition segment over their useful lives. It is a key indicator of the capital intensity required to sustain the segment's infrastructure and intellectual property.